 |
PDBsum entry 6tzh
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
1,2,3-Triazolylmethaneboronate: a structure activity relationship study of a class of β-Lactamase inhibitors against acinetobacter baumannii cephalosporinase.
|
 |
|
Authors
|
 |
E.Caselli,
F.Fini,
M.L.Introvigne,
M.Stucchi,
M.A.Taracila,
E.R.Fish,
K.A.Smolen,
P.N.Rather,
R.A.Powers,
B.J.Wallar,
R.A.Bonomo,
F.Prati.
|
 |
|
Ref.
|
 |
ACS Infect Dis, 2020,
6,
1965-1975.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Boronic acid transition state inhibitors (BATSIs) are known reversible covalent
inhibitors of serine β-lactamases. The selectivity and high potency of specific
BATSIs bearing an amide side chain mimicking the β-lactam's amide side chain
are an established and recognized synthetic strategy. Herein, we describe a new
class of BATSIs where the amide group is replaced by a bioisostere triazole;
these compounds were designed as molecular probes. To this end, a library of 26
α-triazolylmethaneboronic acids was synthesized and tested against the
clinically concerning Acinetobacter-derived cephalosporinase, ADC-7. In
steady state analyses, these compounds demonstrated K
|
 |
|
|
|
|
 |